NCT05763641
| TAD After Chemotherapy in Locally Advanced Breast Cancer | No drug interventions | Not Available | Not Available | recruiting |
NCT05766800
| Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung Cancer | | treatment | 2 | recruiting |
NCT06120387
| Combined Postoperative Radiotherapy With Kidney Sparing Surgery for Locally Advanced High-risk Ureteral Cancer | No drug interventions | Not Available | Not Available | recruiting |
NCT01216345
| Cetuximab + Gemox in Biliary Tract Cancer | | treatment | 2 | completed |
NCT06416007
| Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors | No drug interventions | treatment | 2 | recruiting |
NCT00911170
| PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study | | supportive_care | 3 | completed |
NCT00378313
| A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer | | treatment | 2 | completed |
NCT05868317
| Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer | | treatment | 2 | active_not_recruiting |
NCT03093922
| A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer | | treatment | 2 | active_not_recruiting |
NCT06102057
| PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC | No drug interventions | treatment | 2 | recruiting |
NCT05679674
| Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer | No drug interventions | treatment | Not Available | recruiting |
NCT05576480
| SCRT Sequential Penpulimab in Combination With CAPEOX in the Neoadjuvant Treatment of MSS Locally Advanced Rectal Cancer | | treatment | 2 | not_yet_recruiting |
NCT03024489
| Palbociclib With Cetuximab and IMRT for Locally Advanced Squamous Cell Carcinoma | | treatment | 1 / 2 | active_not_recruiting |
NCT00819169
| QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors | | treatment | 1 / 2 | terminated |
NCT01327612
| Open Label Extension Study of Conatumumab and Ganitumab (AMG 479) | | treatment | 2 | completed |
NCT04585750
| The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) | | treatment | 1 / 2 | recruiting |
NCT03644056
| Dose-escalation Study of IMC-001 in Subject With Metastatic or Locally-advanced Solid Tumors | | other | 1 | completed |
NCT01318642
| Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas | | treatment | 2 | terminated |
NCT06020430
| Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy | No drug interventions | treatment | Not Available | recruiting |
NCT05877573
| Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for Locally Advanced,High-Risk,MSS Rectal Cancer | | treatment | Not Available | recruiting |
NCT05802394
| The Value of Molecular Residual Disease Monitoring Based on ctDNA in Borderline Resectable or Locally Advanced Pancreatic Cancer | No drug interventions | treatment | Not Available | recruiting |